Ignite Creation Date:
2024-05-06 @ 8:22 PM
Last Modification Date:
2024-10-26 @ 3:26 PM
Study NCT ID:
NCT06355336
Status:
RECRUITING
Last Update Posted:
2024-06-25
First Post:
2024-03-21
Brief Title:
Real World Prostate Cancer Registry
Sponsor:
Cincinnati Cancer Advisors
Organization:
Cincinnati Cancer Advisors
Study Overview
Official Title:
Patient Reported Data on Prostate Cancer Diagnosis Management and Outcome Real World Prostate Cancer Registry
Status:
RECRUITING
Status Verified Date:
2024-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
RWPCR
Brief Summary:
Prostate cancer is the most common cancer diagnosed in men in the USA with 268490 cases diagnosed in 2022 constituting 27 of male cancers and 34500 deaths 11 occurred in same year1 Prostate cancer is a very heterogeneous disease that has different presentations molecular and pathological features stages and disease biology The treatment options are dependent on the disease stage its features and the patients condition and preferences The disease outcome also varies significantly due to the previous heterogeneity of the features in addition to other social determinants of health
Therefore it is critical to obtain real-world data that reflects the actual patterns of prostate cancer presentation work up management and outcome Real World Prostate Cancer Registry RWPCR aims at compiling real world data from patients presented with prostate cancer in the tristate area The data collection will be prospective and longitudinal including patients demographics and disease characteristics work up management and outcome
Therefore it is critical to obtain real-world data that reflects the actual patterns of prostate cancer presentation work up management and outcome Real World Prostate Cancer Registry RWPCR aims at compiling real world data from patients presented with prostate cancer in the tristate area The data collection will be prospective and longitudinal including patients demographics and disease characteristics work up management and outcome
Detailed Description:
Real World Prostate Cancer Registry RWPCR aims at compiling real world data from patients presented with prostate cancer in the tristate area The data collection will be prospective and longitudinal including patients demographics and disease characteristics work up management and outcome
Primary Objectives Describing the patterns of prostate cancer presentation management and outcome in the studied population Identify any impact of the compiled variables on treatment selection work up and outcome
Secondary Objectives Identify any gaps and variations in the delivery of care challenges and needs to optimize management of the disease and improve patients outcome
Improve awareness and facilitate enrollment into clinical trials and research studies
Data will be collected directly from patients This data will be collected over 10 years with three years of enrollment and seven years of follow-up Patients provide e-consent and then get login credentials to complete the e-forms which can be edited and updated by the patient 6 monthly reminders will be sent to the patients to complete 6 monthly follow-ups
Research staff may contact patients to offer opportunities to participate in clinical trials if eligible A gift card will be provided to the patient for the initial survey submission A gift card will also be provided to the patient for each 6 month follow up submission
Primary Objectives Describing the patterns of prostate cancer presentation management and outcome in the studied population Identify any impact of the compiled variables on treatment selection work up and outcome
Secondary Objectives Identify any gaps and variations in the delivery of care challenges and needs to optimize management of the disease and improve patients outcome
Improve awareness and facilitate enrollment into clinical trials and research studies
Data will be collected directly from patients This data will be collected over 10 years with three years of enrollment and seven years of follow-up Patients provide e-consent and then get login credentials to complete the e-forms which can be edited and updated by the patient 6 monthly reminders will be sent to the patients to complete 6 monthly follow-ups
Research staff may contact patients to offer opportunities to participate in clinical trials if eligible A gift card will be provided to the patient for the initial survey submission A gift card will also be provided to the patient for each 6 month follow up submission
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None